八尾徳洲会総合病院は、大阪府八尾市にある民間病院である。徳洲会の病院としては全国で4番目の病院である。大阪府指定がん診療連携拠点病院。NPO法人卒後臨床研修評価機構認定証発行病院。

During the past decade, Yao Tokushukai General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yao Tokushukai General Hospital" are "Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Yao Tokushukai General Hospital" in a lesser frequency.

Most popular intervention types in "Yao Tokushukai General Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yao Tokushukai General Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yao Tokushukai General Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yao Tokushukai General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yao Tokushukai General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".